To confirm whether the TGF-β1/Smad2/3 pathway was activated in cervical cancer cells, we examined the expression of TGF-β1 and TβRI in cervical cancer cell lines (HeLa, HT-3, C33A, SiHa and U14) and HCerEpiC cells. Here, SMAD2 is linked to cervical carcinoma.